17.12.2014 • News

Stratmann to Head Lanxess’ New Investor Function

With effect from April 1, 2015, German chemical producer Lanxess will merge its group functions Treasury (TR) and Investor Relations (IR) into a new double function called Treasury & Investor Relations (TIR) and headed by Oliver Stratmann, who has led the IR team since 2008.

Lanxess said Christoph Koch, head of Treasury since 2008, will leave the company "at his own request," effective March 31, 2015.

With the appointment of Stratmann, CEO Matthias Zachert said Lanxess will be able to "efficiently merge our financial markets activities and communication under the leadership of a very experienced capital market specialist."

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read